ERBB4 and lung adenocarcinoma: Trajectory analysis identified ERBB4, SEMA4A, GCNT2 and SOX4 as key factors in AT2 cells that may promote cell proliferation, migration, or epithelial-mesenchymal transition (EMT) during the progression of lung adenocarcinoma (LUAD).